SK284076B6 - Deriváty benzopyrano[3,4-f]chinolínov, ich použitie a farmaceutické kompozície ich obsahujúce - Google Patents

Deriváty benzopyrano[3,4-f]chinolínov, ich použitie a farmaceutické kompozície ich obsahujúce Download PDF

Info

Publication number
SK284076B6
SK284076B6 SK1196-2000A SK11962000A SK284076B6 SK 284076 B6 SK284076 B6 SK 284076B6 SK 11962000 A SK11962000 A SK 11962000A SK 284076 B6 SK284076 B6 SK 284076B6
Authority
SK
Slovakia
Prior art keywords
carbon atoms
twelve carbon
group
twelve
alkyl
Prior art date
Application number
SK1196-2000A
Other languages
English (en)
Slovak (sk)
Other versions
SK11962000A3 (sk
Inventor
Michael J. Coughlan
Michael E. Kort
James P. Edwards
Todd K. Jones
Original Assignee
Abbott Laboratories
Ligand Pharmaceuticals, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbott Laboratories, Ligand Pharmaceuticals, Inc. filed Critical Abbott Laboratories
Publication of SK11962000A3 publication Critical patent/SK11962000A3/sk
Publication of SK284076B6 publication Critical patent/SK284076B6/sk

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Cosmetics (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Cephalosporin Compounds (AREA)
SK1196-2000A 1998-02-13 1999-02-15 Deriváty benzopyrano[3,4-f]chinolínov, ich použitie a farmaceutické kompozície ich obsahujúce SK284076B6 (sk)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/023,913 US6380207B2 (en) 1998-02-13 1998-02-13 Glucocortiocoid-selective antiinflammatory agents
PCT/US1999/003210 WO1999041257A1 (en) 1998-02-13 1999-02-15 Glucocorticoid-selective antiinflammatory agents

Publications (2)

Publication Number Publication Date
SK11962000A3 SK11962000A3 (sk) 2001-03-12
SK284076B6 true SK284076B6 (sk) 2004-09-08

Family

ID=21817891

Family Applications (1)

Application Number Title Priority Date Filing Date
SK1196-2000A SK284076B6 (sk) 1998-02-13 1999-02-15 Deriváty benzopyrano[3,4-f]chinolínov, ich použitie a farmaceutické kompozície ich obsahujúce

Country Status (23)

Country Link
US (1) US6380207B2 (pt)
EP (1) EP1053240B1 (pt)
JP (1) JP2002503666A (pt)
KR (1) KR20010040940A (pt)
CN (1) CN1153771C (pt)
AT (1) ATE237620T1 (pt)
AU (1) AU760511B2 (pt)
BG (1) BG64213B1 (pt)
BR (1) BR9907847A (pt)
CA (1) CA2320911A1 (pt)
DE (1) DE69906938T2 (pt)
DK (1) DK1053240T3 (pt)
ES (1) ES2197618T3 (pt)
HU (1) HUP0100846A3 (pt)
IL (1) IL137509A0 (pt)
NO (1) NO20004052L (pt)
NZ (1) NZ506012A (pt)
PL (1) PL342999A1 (pt)
PT (1) PT1053240E (pt)
SK (1) SK284076B6 (pt)
TR (1) TR200002345T2 (pt)
WO (1) WO1999041257A1 (pt)
ZA (1) ZA99533B (pt)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6566372B1 (en) * 1999-08-27 2003-05-20 Ligand Pharmaceuticals Incorporated Bicyclic androgen and progesterone receptor modulator compounds and methods
ES2246292T3 (es) 2000-10-30 2006-02-16 Pfizer Products Inc. Moduladores de receptor glucocorticoide.
US7026484B2 (en) * 2001-02-23 2006-04-11 Ligand Pharmaceuticals Incorporated Tricyclic androgen receptor modulator compounds and methods
CA2473886C (en) 2002-01-22 2012-08-21 The Regents Of The University Of California Non-steroidal ligands for the glucocorticoid receptor, compositions and uses thereof
KR100492913B1 (ko) * 2002-08-23 2005-06-03 주식회사 태평양 피부 감작 및 자극을 완화하는 피부 외용제 조성물
EP2298315A1 (en) 2002-08-28 2011-03-23 Harbor BioSciences, Inc. Therapeutic treatment methods
US20040220153A1 (en) * 2002-09-24 2004-11-04 Jost-Price Edward Roydon Methods and reagents for the treatment of diseases and disorders associated with increased levels of proinflammatory cytokines
DE20301728U1 (de) * 2002-10-11 2004-03-11 Ligand Pharmaceuticals, Inc., San Diego 5-substituierte 7,9-Difluor-5H-Chromeno(3,4-f) -Chinolin-Verbindungen als selektive Progesteronrezeptormodulator-Verbindungen
AU2003258050A1 (en) * 2002-10-11 2004-05-04 Ligand Pharmaceuticals Incorporated 5-cycloalkenyl 5h-chromeno(3,4-f)quinoline derivatives as selective progesterone receptor modulator compounds
CA2501833A1 (en) * 2002-10-11 2004-04-22 Ligand Pharmaceuticals Incorporated 5-(1',1'-cycloalkyl/alkenyl)methylidene 1,2-dihydro-5h-chromeno[3,4-f]quinolines as selective progesterone receptor modulator compounds
US7235662B2 (en) * 2003-06-11 2007-06-26 Bristol-Myers Squibb Company Modulators of the glucocorticoid receptor and method
MXPA06001751A (es) * 2003-08-22 2006-05-12 Ligand Pharm Inc Derivados de 6-cicloamino-2-quinolinona como compuestos moduladores de receptor de androgeno.
TW200517114A (en) 2003-10-15 2005-06-01 Combinatorx Inc Methods and reagents for the treatment of immunoinflammatory disorders
DE602004031356D1 (de) 2003-11-21 2011-03-24 Zalicus Inc Verfahren und reagenzien zur behandlung von entzündlichen erkrankungen
US8519158B2 (en) 2004-03-12 2013-08-27 Ligand Pharmaceuticals Incorporated Androgen receptor modulator compounds and methods
BRPI0609191B8 (pt) * 2005-06-17 2021-05-25 Ligand Pharm Inc métodos e compostos moduladores de receptor de androgênio
WO2007025303A2 (en) 2005-08-26 2007-03-01 The Regents Of The University Of California Non-steroidal antiandrogens
JP2009514969A (ja) 2005-11-09 2009-04-09 コンビナトアールエックス インコーポレーティッド 医学的状態を治療するための方法、組成物、およびキット
CA2632531A1 (en) * 2005-12-09 2007-06-14 F. Hoffmann-La Roche Ag Propionamide compounds as antiinflammatory agents
WO2007065828A1 (en) * 2005-12-09 2007-06-14 F. Hoffmann-La Roche Ag Glucocorticoid receptor modulators as antiinflammatory agents
US8269612B2 (en) 2008-07-10 2012-09-18 Black & Decker Inc. Communication protocol for remotely controlled laser devices
US20100092479A1 (en) * 2008-08-18 2010-04-15 Combinatorx (Singapore) Pte. Ltd. Compositions and methods for treatment of viral diseases
US9908182B2 (en) 2012-01-30 2018-03-06 Black & Decker Inc. Remote programming of a power tool
US20130327552A1 (en) 2012-06-08 2013-12-12 Black & Decker Inc. Power tool having multiple operating modes
US8919456B2 (en) 2012-06-08 2014-12-30 Black & Decker Inc. Fastener setting algorithm for drill driver
US10011006B2 (en) 2013-08-08 2018-07-03 Black & Decker Inc. Fastener setting algorithm for drill driver
WO2020214834A1 (en) 2019-04-19 2020-10-22 Ligand Pharmaceuticals Inc. Crystalline forms and methods of producing crystalline forms of a compound

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5696130A (en) 1994-12-22 1997-12-09 Ligand Pharmaceuticals Incorporated Tricyclic steroid receptor modulator compounds and methods
EP1043325B1 (en) 1994-12-22 2004-06-16 Ligand Pharmaceuticals Incorporated Steroid receptor modulator compounds and methods
US5693133A (en) 1995-05-10 1997-12-02 Akzo Nobel Nv Asbestos free roof coatings

Also Published As

Publication number Publication date
ATE237620T1 (de) 2003-05-15
US6380207B2 (en) 2002-04-30
IL137509A0 (en) 2001-07-24
HUP0100846A3 (en) 2003-03-28
SK11962000A3 (sk) 2001-03-12
EP1053240B1 (en) 2003-04-16
TR200002345T2 (tr) 2000-11-21
DE69906938D1 (de) 2003-05-22
EP1053240A1 (en) 2000-11-22
NO20004052D0 (no) 2000-08-11
HK1033309A1 (en) 2001-08-24
DK1053240T3 (da) 2003-08-11
KR20010040940A (ko) 2001-05-15
PL342999A1 (en) 2001-07-16
CA2320911A1 (en) 1999-08-19
CN1153771C (zh) 2004-06-16
BR9907847A (pt) 2001-01-09
CN1297451A (zh) 2001-05-30
JP2002503666A (ja) 2002-02-05
NO20004052L (no) 2000-10-12
PT1053240E (pt) 2003-09-30
BG64213B1 (bg) 2004-05-31
ZA99533B (en) 1999-07-26
BG104698A (en) 2001-05-31
WO1999041257A1 (en) 1999-08-19
ES2197618T3 (es) 2004-01-01
NZ506012A (en) 2003-03-28
US20010049377A1 (en) 2001-12-06
DE69906938T2 (de) 2004-02-26
AU2600399A (en) 1999-08-30
AU760511B2 (en) 2003-05-15
HUP0100846A2 (hu) 2001-09-28

Similar Documents

Publication Publication Date Title
SK284076B6 (sk) Deriváty benzopyrano[3,4-f]chinolínov, ich použitie a farmaceutické kompozície ich obsahujúce
EP1208095B1 (en) Dibenzopyrans as glucocorticoid receptor antagonists for treatment of diabetes
CA2000894A1 (en) Heterocyclic compounds
US6436986B1 (en) Glucocorticoid receptor antagonists for treatment of diabetes
CA2320943A1 (en) Glucocorticoid-selective anti-inflammatory agents
KR20220141331A (ko) P2x3 조정제
GB1581500A (en) Pyridobenzodiazepines
IE57624B1 (en) Novel beta-carbolines,their preparation and use as medicinal agents
AU2002224086B8 (en) Indole derivatives and use thereof in medicines
US5770611A (en) Indole derivatives as 5HT1 -like agonists
US5981521A (en) Tetrahydroisoquinoline derivatives as LHRH antagonists
CZ20002894A3 (cs) Protizánětlivé prostředky selektivní na glukokortikoidy
EP0760375B1 (en) Antitumor indolopyprolocarbazole derivative
SAIGA et al. Synthesis of 1, 2, 3, 4-tetrahydro-β-carboline derivatives as hepatoprotective agents. IV. Positional isomers of 1, 2, 3, 4-tetrahydro-2-methylthiothiocarbonyl-β-carboline-3-carboxylic acid and its 1-alkylated derivatives
CA1131236A (en) 2,9-dioxatricyclo[4,3,1,0 su3,7 xx]decane derivatives, processes for their preparation and pharmaceutical compositions thereof
HK1033309B (en) Glucocorticoid-selective antiinflammatory agents
MXPA00007902A (en) Glucocorticoid-selective antiinflammatory agents
US4123545A (en) N-Propyl-3(β-hydroxyethyl)-3-(meta-hydroxyphenyl)-pyrrolidine
KR850000262B1 (ko) 벤즈 아체핀 유도체의 제조방법
IE46003B1 (en) 3-phenoxy-n-substituted morphinan derivatives, their manufacture and pharmaceutical preparations containing them
US20040019070A1 (en) Pyrrole-condensed morphinoid derivatives
JPH0141640B2 (pt)
JPS61106513A (ja) アミノナフタセン誘導体とその製法
MXPA00007944A (en) Glucocorticoid-selective anti-inflammatory agents
JPWO1998025900A1 (ja) 抗腫瘍活性を有する化合物